Estrategias preventivas del Síndrome Coronario Agudo: Revisión de alcance
Open Access
- 1 July 2026
- journal article
- Published by Editorial Cientifica Doso in Horizon Nexus Journal
- Vol. 4 (3) , 315-344
Abstract
Acute Coronary Syndrome (ACS) is one of the leading causes of cardiovascular morbidity and mortality worldwide. Its prevention through primary, secondary, and tertiary strategies helps reduce the incidence of events, recurrences, and associated complications. The objective of this study is to analyze the ACS prevention strategies described in recent scientific literature. A scoping review with a qualitative approach was conducted based on the Joanna Briggs Institute (JBI) methodology and PRISMA-ScR. The search was performed in PubMed, Scopus, SciELO, and BVS, including studies published between 2020 and 2026 in Spanish, English, and Portuguese. A total of 26 studies were included, with secondary prevention predominating (73%), followed by tertiary prevention (15%) and primary prevention (12%). The main strategies identified were the control of cardiovascular risk factors, intensive lipid-lowering therapy, personalized antiplatelet therapy, cardiac rehabilitation, digital interventions, optimization of medication, and prevention of post-revascularization complications. This study suggests that the prevention of ACS requires a comprehensive approach based on pharmacological, educational, and behavioral interventions. Family and community nursing plays an essential role through health education, continuous follow-up, promotion of self-care, and the implementation of evidence-based strategies to reduce cardiovascular riskKeywords
This publication has 42 references indexed in Scilit:
- Standard modifiable cardiovascular risk factors and acute coronary syndrome free survivalAtherosclerosis, 2026
- A polypill strategy for lipid lowering and anti-platelet therapy after acute coronary syndrome: A pilot randomized controlled trialAmerican Journal of Preventive Cardiology, 2026
- Eligibility for Icosapent ethyl in patients undergoing cardiac rehabilitation: A real-world cohort studyInternational Journal of Cardiology, 2025
- Comparison of clopidogrel monotherapy versus prolonged DAPT based on the GRACE risk score in patients with acute coronary syndromes at high ischemic and bleeding risk: a subgroup analysis of the OPT-BIRISK randomized clinical trialEuropean Journal of Pharmacology, 2025
- Icosapent ethyl: From the REDUCE-IT trial to clinical practiceClínica e Investigación en Arteriosclerosis (English Edition), 2025
- Eligibility for and practical implications of Semaglutide in overweight and obese patients with acute coronary syndromeInternational Journal of Cardiology, 2025
- Effects of a stepwise, structured LDL-C lowering strategy in patients post-acute coronary syndromeNetherlands Heart Journal, 2024
- Association of Glutamate Infusion With Risk of Acute Kidney Injury After Coronary Artery Bypass SurgeryJAMA Network Open, 2024
- Prevention of contrast induced-acute kidney injury using coenzyme Q10 in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary interventionEuropean Journal of Clinical Pharmacology, 2023
- The Scope of Practice for Primary Cardiovascular Disease Prevention Expanded to Advanced Practice Providers: What Does the Data Show?Current Cardiology Reports, 2023